Santhera News, Researches, Clinical Trials and Articles

About us

We do not want children to die from a disease that can be cured. We want to give hope to families and ensure that all children with DMD are treated and regain their health.

Powered by Hostinger

Latest Articles

DYNE-251 Phase 3 FORZETTO Clinical Trial of Z-Rostudirsen Officially Begins for DMD

Research May 27, 2026 0

Dyne Therapeutics has announced the start of the Dyne...

What Is a Spirometry Test in Duchenne Muscular Dystrophy (DMD) and Why Is It Performed?

Care Guidelines May 23, 2026 0

A spirometry test in Duchenne muscular dystrophy is a...

Age-Based Assistive Devices for Duchenne Muscular Dystrophy: Complete Guide by Stage

Care Guidelines May 22, 2026 0

Age-based assistive devices for Duchenne muscular dystrophy (DMD) plays...

Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy

Approved Therapies December 26, 2024 5

A genetic condition known as Duchenne muscular dystrophy (DMD)...

Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy

Editorials April 10, 2026 9

The landscape of potential new gene therapies for Duchenne...

Explore Of 5 Phases In Drug Development

DMD March 22, 2025 0

The process of drug development is a highly intricate,...

Duchenne MD

Genetic

Care Guidelines

Health Guidelines

Santhera

Must Read

Investigational New Drug (IND) Clearance for Duchenne Muscular Dystrophy: Process, Trials & Future Therapies

Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy

Hydrotherapy in Duchenne Muscular Dystrophy (DMD): Benefits, Exercises, and Clinical Evidence

About us

Latest Articles

DYNE-251 Phase 3 FORZETTO Clinical Trial of Z-Rostudirsen Officially Begins for DMD

What Is a Spirometry Test in Duchenne Muscular Dystrophy (DMD) and Why Is It Performed?

Age-Based Assistive Devices for Duchenne Muscular Dystrophy: Complete Guide by Stage

Most Popular

Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy

Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy

Explore Of 5 Phases In Drug Development